Skin Tissue Engineering is an interdisciplinary field that focuses on creating artificial skin substitutes for therapeutic applications, wound healing, and reconstructive surgery. It aims to develop functional skin equivalents that mimic the structure and function of native skin tissue. This involves combining cells, biomaterial scaffolds, and signaling factors to promote tissue formation. Primary cell types utilized in skin tissue engineering include keratinocytes, fibroblasts, and sometimes melanocytes, which are cultured on biocompatible scaffolds. These scaffolds provide a three-dimensional structure resembling the extracellular matrix, guiding cell organization and promoting tissue development. Incorporating vascularization strategies is crucial to ensure proper blood supply and nutrient delivery to the engineered skin tissue. Various techniques, such as 3D printing and electrospinning, are employed to create scaffolds with optimal physical and mechanical properties. Skin tissue engineering holds significant promise for treating burns, chronic wounds, and skin disorders. Engineered skin grafts can offer a viable alternative to traditional skin grafts, reducing scarring and improving cosmetic outcomes. Challenges in skin tissue engineering include achieving full thickness skin regeneration, promoting hair follicle and sweat gland formation, and addressing immunological responses to the engineered grafts. Advances in biomaterials, stem cell research, and tissue culture techniques continue to address these challenges and improve the success of skin tissue engineering.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States